UNSPSC 51393314: Spirofylline

This classification denotes a bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 000F949089. European Medicines Agency schedules Spirofylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10627MIG. Spirofylline generally arises in the molecular formula C24H28N6O5.

UNSPSC 51393314 Spirofylline is a Commodity code that does not align with the state and local contract opportunities currently tagged under it. The recent solicitations show minimal relevant activity: Seminole County, Florida issued an IFB for naloxone and drug deactivation systems (two distinct products with no spirofylline component), and the Texas Health and Human Services Commission issued an RFI exploring direct-to-manufacturer prescription fulfillment models. Neither procurement involves spirofylline as a product line, and the code does not show meaningful state and local buying activity in concrete, spirofylline-related scope.

The mismatch between the code's nominal product (spirofylline, a pharmaceutical compound) and the actual opportunities posted against it suggests either a tagging error in the underlying procurement records or dormant activity under the code. State and local governments may procure spirofylline through pharmacy benefit programs, health department acquisitions, or emergency medical services contracts, but the recent-opportunities block provides no evidence of current solicitation volume or repeat buyer patterns. Without active, relevant opportunities to characterize issuing-body mix, geographic concentration, or representative work, the code presents limited visibility for business development.